Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

87Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

Abstract

Essentials Currently, DOACs are given at fixed doses and do not require laboratory monitoring. Direct oral anticoagulant-specific measurements were performed at trough and peak. Patients who developed bleeding events showed higher DOAC plasma levels at peak. This study suggests the need of a more accurate DOAC dose assessment. Background: Direct oral anticoagulants (DOACs) are administered at fixed dose. The aim of the study was to evaluate the relationship between DOAC C-trough or C-peak plasma levels and bleeding complications in patients with non-valvular atrial fibrillation (NVAF). Methods: Five hundred sixty five consecutive naive NVAF patients were enrolled. The DOAC measurements at C-trough and at C-peak (available in 411 patients) were performed at steady state, within the first month of treatment. Major bleeding (MB), clinically relevant non-major bleeding (CRNMB), and minor bleeding (MinB), occurring during 1 year of follow-up after blood sampling, were recorded. For each DOAC, interval of C-trough and C-peak levels was subdivided into four equal classes and results were attributed to these classes; the median values of results were also calculated. Results: Two hundred eight patients were on apixaban, 185 on dabigatran, and 172 on rivaroxaban. For 1-[qqqdeletezzz] year follow up for all patients, we observed: 19 MB (3.36%), 6 CRNMB (1.06%), and 47 MinB (8.31%). The prevalence of bleeding patients with anticoagulant levels in the upper classes of C-peak activity (II + III + IV) was higher than that in the lowest class. Normalized results of C-peak levels were higher in patients with bleeding than in those without bleeding. Conclusions: Bleeding complications during DOAC treatment were more frequent among atrial fibrillation (AF) patients with higher C-peak anticoagulant levels. In addition to a previous study that showed an increased risk of thrombotic complications in the patients with low C-trough levels, this study seems to indicate that patients with NVAF on DOACs would need a more accurate definition of their optimal therapeutic window.

References Powered by Scopus

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

4100Citations
N/AReaders
Get full text

Idarucizumab for dabigatran reversal

1406Citations
N/AReaders
Get full text

Oral anticoagulant therapy - Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines

1357Citations
N/AReaders
Get full text

Cited by Powered by Scopus

2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

272Citations
N/AReaders
Get full text

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

143Citations
N/AReaders
Get full text

Direct oral anticoagulant plasma levels’ striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience

131Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Testa, S., Legnani, C., Antonucci, E., Paoletti, O., Dellanoce, C., Cosmi, B., … Palareti, G. (2019). Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants. Journal of Thrombosis and Haemostasis, 17(7), 1064–1072. https://doi.org/10.1111/jth.14457

Readers over time

‘19‘20‘21‘22‘23‘24‘2506121824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 31

67%

Researcher 11

24%

Professor / Associate Prof. 3

7%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 30

63%

Pharmacology, Toxicology and Pharmaceut... 14

29%

Nursing and Health Professions 2

4%

Biochemistry, Genetics and Molecular Bi... 2

4%

Save time finding and organizing research with Mendeley

Sign up for free
0